Your browser doesn't support javascript.
loading
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.
Kim, Youn H; Bagot, Martine; Pinter-Brown, Lauren; Rook, Alain H; Porcu, Pierluigi; Horwitz, Steven M; Whittaker, Sean; Tokura, Yoshiki; Vermeer, Maarten; Zinzani, Pier Luigi; Sokol, Lubomir; Morris, Stephen; Kim, Ellen J; Ortiz-Romero, Pablo L; Eradat, Herbert; Scarisbrick, Julia; Tsianakas, Athanasios; Elmets, Craig; Dalle, Stephane; Fisher, David C; Halwani, Ahmad; Poligone, Brian; Greer, John; Fierro, Maria Teresa; Khot, Amit; Moskowitz, Alison J; Musiek, Amy; Shustov, Andrei; Pro, Barbara; Geskin, Larisa J; Dwyer, Karen; Moriya, Junji; Leoni, Mollie; Humphrey, Jeffrey S; Hudgens, Stacie; Grebennik, Dmitri O; Tobinai, Kensei; Duvic, Madeleine.
  • Kim YH; Stanford University, Stanford, CA, USA. Electronic address: younkim@stanford.edu.
  • Bagot M; Hôpital Saint Louis, APHP, Inserm U976, Université Paris 7, Paris, France.
  • Pinter-Brown L; University of California Irvine, Irvine, CA, USA.
  • Rook AH; University of Pennsylvania, Philadelphia, PA, USA.
  • Porcu P; Thomas Jefferson University, Philadelphia, PA, USA.
  • Horwitz SM; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Whittaker S; Guy's and St Thomas' Hospital, London, UK.
  • Tokura Y; Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Vermeer M; Leiden University, Leiden, Netherlands.
  • Zinzani PL; Institute of Hematology "Seràgnoli", University of Bologna, Bologna, Italy.
  • Sokol L; Moffitt Cancer Center, Tampa, FL, USA.
  • Morris S; Guy's and St Thomas' Hospital, London, UK.
  • Kim EJ; University of Pennsylvania, Philadelphia, PA, USA.
  • Ortiz-Romero PL; Department of Dermatology, Institute i+12, Hospital 12 de Octubre Medical School, University Complutense, Madrid, Spain.
  • Eradat H; UCLA Medical Center, Los Angeles, CA, USA.
  • Scarisbrick J; University Hospital Birmingham, Birmingham, UK.
  • Tsianakas A; University Hospital MÜnster, MÜnster, Germany.
  • Elmets C; University of Alabama, Birmingham, AL, USA.
  • Dalle S; Hospices Civils de Lyon, Claude Bernard Lyon 1 University, Lyon, France.
  • Fisher DC; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Halwani A; University of Utah, Salt Lake City, UT, USA.
  • Poligone B; Rochester Skin Lymphoma Center, Fairport, NY, USA.
  • Greer J; Vanderbilt University Medical Center, Nashville, TN, USA.
  • Fierro MT; University of Turin, Turin, Italy.
  • Khot A; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Moskowitz AJ; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Musiek A; Washington University, St Louis, MO, USA.
  • Shustov A; University of Washington, Seattle, WA, USA.
  • Pro B; Northwestern University, Chicago, IL, USA.
  • Geskin LJ; Columbia University Medical Center, New York, NY, USA.
  • Dwyer K; Kyowa Kirin Pharmaceutical Development, Princeton, NJ, USA.
  • Moriya J; Kyowa Kirin Pharmaceutical Development, Princeton, NJ, USA.
  • Leoni M; Kyowa Kirin Pharmaceutical Development, Princeton, NJ, USA.
  • Humphrey JS; Kyowa Kirin Pharmaceutical Development, Princeton, NJ, USA.
  • Hudgens S; Clinical Outcome Solutions, Tucson, AZ, USA.
  • Grebennik DO; Kyowa Kirin Pharmaceutical Development, Princeton, NJ, USA.
  • Tobinai K; National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Duvic M; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lancet Oncol ; 19(9): 1192-1204, 2018 09.
Article en En | MEDLINE | ID: mdl-30100375

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma Cutáneo de Células T / Micosis Fungoide / Síndrome de Sézary / Inhibidores de Histona Desacetilasas / Anticuerpos Monoclonales Humanizados / Antineoplásicos Inmunológicos / Vorinostat Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged País como asunto: America do norte / Asia / Europa / Oceania Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma Cutáneo de Células T / Micosis Fungoide / Síndrome de Sézary / Inhibidores de Histona Desacetilasas / Anticuerpos Monoclonales Humanizados / Antineoplásicos Inmunológicos / Vorinostat Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged País como asunto: America do norte / Asia / Europa / Oceania Idioma: En Año: 2018 Tipo del documento: Article